CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event Executive or director change
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market buy CFO bought 100,000 shares at $0.10 ($10,000)
- 4 Open-market buy Director bought 700,000 shares at $0.11 ($77,000)
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
Page 43 of 63 · 1,250 filings